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ABSTRACT
Objective Thousands of complex-disease single-
nucleotide polymorphisms (SNPs) have been discovered
in genome-wide association studies (GWAS). However,
these intragenic SNPs have not been collectively mined
to unveil the genetic architecture between complex
clinical traits. The authors hypothesize that biological
annotations of host genes of trait-associated SNPs may
reveal the biomolecular modularity across complex-
disease traits and offer insights for drug repositioning.
Methods Trait-to-polymorphism (SNPs) associations
conﬁrmed in GWAS were used. A novel method to
quantify traitetrait similarity anchored in Gene Ontology
annotations of human proteins and information theory
was developed. The results were then validated with the
shortest paths of physical protein interactions between
biologically similar traits.
Results A network was constructed consisting of 280
signiﬁcant intertrait similarities among 177 disease traits,
which covered 1438 well-validated disease-associated
SNPs. Thirty-nine percent of intertrait connections were
conﬁrmed by curators, and the following additional
studies demonstrated the validity of a proportion of the
remainder. On a phenotypic trait level, higher Gene
Ontology similarity between proteins correlated with
smaller ‘shortest distance’ in protein interaction
networks of complexly inherited diseases (Spearman
p<2.2310
 16). Further, ‘cancer traits’ were similar to
one another, as were ‘metabolic syndrome traits’
(Fisher’s exact test p¼0.001 and 3.5310
 7,
respectively).
Conclusion An imputed disease network by
information-anchored functional similarity from GWAS
trait-associated SNPs is reported. It is also demonstrated
that small shortest paths of protein interactions correlate
with complex-disease function. Taken together, these
ﬁndings provide the framework for investigating drug
targets with unbiased functional biomolecular networks
rather than worn-out single-gene and subjective
canonical pathway approaches.
INTRODUCTION
An essential objective of genome-scale sequencing
and functional genomics is to improve on the
paucity of associations between genetic variations
and human diseases or other phenotypic traits (such
as birth weight) and the impact of epigenetic modi-
ﬁcations. From these upstream genetic causes, the
ultimate goal is to achieve an improved form of
personalized medicine based on individual patient’s
genetic variation.
1 Genetic disorders are often cate-
gorized as single-gene diseases or as complex, multi-
gene diseases such as cancers and diabetes. Typical
examples of single-gene diseases are those of
Mendelian inheritance, caused by mutations in an
individual gene that result in an altered function or
loss of its ability to properly interact with other
genes.
23In contrast, complex diseases arise from the
interplay of many different genes and single-nucleo-
tide polymorphisms (SNPs). Although many of these
diseases are common, their driving genetic mecha-
nisms remain poorly understood on a molecular level.
To pinpoint the genes involved in complex
diseases and elucidate their underlying genetic
variations, hundreds of genome-wide association
studies (GWAS) have been carried out and compare
affected individuals with control cohorts. Despite
the fact that many disease alleles have been
discovered, most possess only a small effect size:
OR<1.5.
4 Therefore, it is unlikely that a few SNPs
alone give rise to complex diseases, and it is more
probable that an accumulation of large combina-
tions of SNPs and other forms of genetic variations
disrupt key biological mechanisms and conse-
quently alter normal human physiology.
5
Since the clinical functions of numerous intra-
genic trait-associated SNPs (SNPs located within
gene regions) remain uncharacterized, the genetic
architectures within and between these traits are
thus also poorly understood. For instance, obesity is
a disease that often fundamentally contributes to
many other diseases such as diabetes and hyper-
tension, and indeed obesity-associated genes have
been prioritized in adult-onset diabetes GWAS.
6 7
We therefore hypothesize that there should theo-
retically be some core shared SNPs, genes, or bio-
logical pathways that contribute to or cause
common underlying traits. Such genetic architec-
ture is evident in cancer, where gain-of-function
mutations in oncogenes occur in the same genes
across distinct cancers. Furthermore, these central
genetic architectures can contribute to and link the
diseases found within a particular metatrait,
deﬁned as a class of disorders clinically related in
time (eg, one disease causally precedes another) or
sharing common molecular functions and
processes. For example, oncogenic processes leading
to ‘cancer’ can together be considered a metatrait
that comprises different types of speciﬁc cancers, as
their somatic mutations often overlap genetically
or functionally. Similarly, metabolic syndrome is
considered a metatrait that includes insulin resis-
tance, hypertension, obesity, hyperlipidemia, and
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Research and applicationshypercholesterolemia. Therefore, to elucidate this genetic
underpinning, great emphasis is placed on shared characteristics,
such as symptoms and drug responses, when developing disease
networks
89and their causative genetic networks.
Numerous methods have been developed to construct human
disease networks and can be categorized as either non-SNP-based
or SNP-based methods. Information in electronic medical
records, such as disease correlation or comorbidities, can be
directly applied to construct disease networks.
10 11 Furthermore,
underlying biological disease data, such as mRNA expression
proﬁles
91 2and proteineprotein interactions (including protein
complexes),
11 13 14 can also be employed to infer disease
networks. Additionally, metabolic data, such as adjacent or
mutual biochemical reactions, have also been used in disease
network development.
15 Recently, with the dramatic increase in
genetic variation data and GWAS results, shared intragenic SNPs
and their host genes (the genes physically containing the vari-
ations)
16 have been used to link distinct diseases, both single-
gene inherited diseases
17 18 and complex diseases.
19 However,
unlike single-gene diseases, these early complex-disease network
studies that use simple SNP and gene overlaps have not obtained
the expected modularization results (related diseases highly
connected with each other) because of small dataset sizes.
Speciﬁcally, many diseases were found to be isolated and totally
disconnected from other diseases within the same disease class.
19
Since previous disease network modeling methods have been
mainly based only on analyzing gene overlap or clinical relat-
edness as found in the GWAS or the medical record rather than
biological relatedness, only those diseases with obvious genetic
or clinical connections have been highlighted. Furthermore, the
majority of these networks used Mendelian inheritance facts
from the Online Mendelian Inheritance in Man (OMIM) rather
than complex inheritance patterns from GWAS. Many diseases
are obviously clinically related, eg, the comorbidity between
hypertension and obesity; however, no overlapping genes or
SNPs have been discovered by GWAS to date. Therefore, more
complex ways of relating two diseases and constructing disease
networks must be designed in order to understand their
common pathologies and relatedness, which can further our
ability to treat diseases.
One application of such networks would be drug reposi-
tioning accomplished through the identiﬁcation of shared bio-
logical mechanisms between one treatable disease and one for
which no effective treatment exists. This can be conducted
using network theoretic models in which biological mechanisms
are used to relate diseases and their associated molecular struc-
tures. Novel methodologies that can mechanistically relate
diseases that are observably clinically related but have little or no
shared genetic or physiological underpinning may elucidate
more complex mechanisms and point to therapies that can be
repurposed between the two.
To address this issue, we propose a novel method that builds
diseaseedisease networks that extend well beyond mere shared
SNPs or host gene linkages. To this end, we exploit the semantic
similarity among host genes of validated trait-associated SNPs in
the National Human Genome Research Institute Catalog of
Published Genome-Wide Association Studies (NHGRI GWAS
Catalog)
20 via existing annotations of host genes in Gene
Ontology (GO)
21 to build a similarity network of diseases
with an information theory-based approach. Speciﬁcally, our
method integrates genetic alteration (GWAS) data with stan-
dardized textual descriptions of gene functions and processes
and their inter-relationships in order to characterize the mech-
anistic underpinnings of disease of complex inheritance. We
hypothesize that similarity among clinically related diseases is
reﬂected in the similarity between their constitutive deregulated
processes and functions that can be investigated computation-
ally through the biological annotations associated with their
genes hosting intragenic GWAS SNPs (host genes). Thus, we use
a novel application of GO to computationally examine and
compare data derived from GWAS.
We further analyze our diseaseedisease network using protein
interactions to create a diseaseegene network (which also
contains diseaseedisease, geneegene, and diseaseegene connec-
tions). Integration of protein interaction data allows the identi-
ﬁcation of functional similarity network relationships that can be
explained straightforwardly at the protein level and those that are
most likely due to higher scale biological processes (eg, cell
proliferation associated with cancer disease). Further, this
enhances the current paradigm of ‘targeted’ therapy reposi-
tioning, which implies a ‘protein target’ and is thus better
understood at the protein level, with non-trivial and multi-scale
biological mechanisms unveiled by similarity metrics (GWAS/
SNP/GO). We have previously demonstrated that this gene
information theoretic similarity (ITS) method can accurately
predict protein functions in poorly characterized genes
22 and,
further, can exploit the shared genetic architecture of diseases by
using their common interactions or interaction paths. Thus, we
hypothesize that this sensitive similarity approach could allow
the elucidation of non-trivial associations between trait-associated
genes. Additionally, we constructed our network based on a much
larger number of NHGRI intragenic SNPs than previous studies.
METHODS
The workﬂow of our methodology is shown in ﬁgure 1, and each
component is described as follows. Table 1 provides deﬁnitions
of the major concepts and terms used in this paper.
Data and preprocessing
GWAS dataset ﬁle ‘gwascatalog.txt’ was downloaded on May
25, 2010 from the NHGRI GWAS Catalog (http://genome.gov/
admin).
20 It comprises well-validated associations between 350
complex traits and diseases and 2793 SNPs, of which 1355 are
intergenic, 1137 are intronic, and 144 are exonic. Of the exonic
SNPs, 113 are non-synonymous. Expert curation of the 271
distinct textual terms representing complex traits and diseases
was performed in order to identify synonymous terms (eg,
‘hemoglobin’ and ‘hemoglobin level’) or highly related terms (eg,
‘glioma’ and ‘high grade glioma’), and aggregate their intragenic
SNPs. We resolved these fairly redundant annotations through
manual curation and thus increased the average number of SNPs
associated with any single trait, which resulted in 177 concep-
tual entities (traits) from the 271 NHGRI catalog traits, during
which 131 textual terms were merged with others as 37
conceptual entities, as described in online supplementary table 1.
Hereafter, we refer to these 177 conceptual entities as ‘traits’ or
‘diseases’. A total of 1438 intragenic SNPs associated with these
diseases were included in this study, while 1355 intergenic SNPs
(see table 1 for deﬁnitions) were not.
Host genes of intragenic SNPs were assigned using the default
deﬁnitions and parameters from the Single Nucleotide Poly-
morphism Database (dbSNP) annotations (ﬁle downloaded from
ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/ASN1_ﬂat/
on October 19, 2009). In spite of the rare instances where a SNP
could lead to two distinct genes (sense and anti-sense transcrip-
tion), in dbSNP each SNP is uniquely mapped to a single host
gene.
16 To most accurately determine the inter- or intra-genic
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NHGRI GWAS Catalog does not delineate whether the SNP’s
associated gene is the nearest one or the actual host gene,
making the status often indistinguishable. As a result, 1083
disease host genes were mapped from the 1438 distinct disease-
associated intragenic SNPs.
GO hierarchies
21 and Gene Ontology annotation ﬁles gene2go
and gene_info were downloaded from http://www.geneon-
tology.org/ontology/gene_ontology.obo and ftp://ftp.ncbi.nlm.
nih.gov/gene/DATA/ on May 19, 2009. GO terms classiﬁed as
‘GO molecular functions’ (GO:MF) and ‘GO biological
processes’ (GO:BP) were identiﬁed and analyzed as two distinct
semantic types using the similarity metrics described below. GO
terms from the third semantic type, ‘GO Cellular Components’,
were not included, as it was assumed that membership in
a cellular component geneset is generally not sufﬁcient to
impute functional or mechanistic similarity between genes
underpinning the same complex trait.
The interaction network of gene products (proteins) was
downloaded from the search tool for the retrieval of interacting
genes/proteins (STRING v8.0; http://string.embl.de, last update
on November 17, 2008).
23 The STRING database contains the
most comprehensive dataset to date for proteineprotein inter-
actions and associations and was thus used as the database for
physical protein interactions in humans. Protein interactions
included in this study met the following criteria: (1) species:
Homo sapiens; (2) physical interactions coded in STRING as
‘experimental’, ‘fusion’ (see details in table 1), and ‘other data-
base based methods’ (excluding those exclusively derived from
‘text mining’ to avoid a bias introduced by utilizing protein
interactions discovered via GWAS results); and (3) high conﬁ-
dence scores of at least ‘900’ (available range 0e999) to exclude
lower quality ones. Consequently, 72730 interactions between
pairs found among 7677 proteins were obtained after 1181753
interactions had been ﬁltered out. These data were used in
ﬁgures 2 and 4.
Figure 1 Workﬂow of our methodology. This study demonstrates the non-trivial modularity of biological mechanisms shared by some complex
diseases. Speciﬁcally, complex diseases are connected using biological similarity computations between single-nucleotide polymorphisms (SNPs)
associated by genome-wide association studies (GWAS) with complex traits. First, geneegene similarity in Gene Ontology (GO) was calculated at
a genome scale using an information theory similarity (ITS) measure validated previously. For a pair of genes in the STRING database, the shortest
protein interaction distance is shown correlated with their biological similarity obtained by Gene_ITS using GO annotations (ﬁgure 2). Second, host
genes were mapped to complex traits using the NHGRI GWAS Catalog and dbSNP database, and the traitetrait ITS of their associated traits was
derived from results calculated in step 1. A disease similarity network was constructed by choosing the signiﬁcant traitetrait similarity (ﬁgure 3).
Metatrait modules were extended by their shortest paths between host genes with signiﬁcant information similarities, due to the validated reverse
correlation between them (ﬁgure 4).
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Research and applicationsCalculation of shortest path(s) and shortest distance between
two proteins in a protein interaction network
In a protein interaction network consisting of nodes (proteins)
and edges between these nodes (direct interactions between two
proteins), the shortest paths between a pair of proteins are the
routes with minimal number of edges among all possible routes
connecting the two proteins.
24 Note that different paths may
meet the criteria of the shortest path, and thus more than one
set of edges (paths) can result. The cardinality of the shortest
path between two proteins is calculated as the count of its
distinct edges and is termed the ‘shortest distance between two
proteins’.
8 A breath-ﬁrst algorithm was implemented on the
protein interaction network (undirected graph) in-house as
classically described.
24 The metric of shortest distance between
two proteins was used as a gold standard in the validation
provided in ﬁgures 2 and 4, since pairs of proteins with smaller
‘shortest distances’ have previously been established as more
functionally related than those with longer ones.
25 26 Further-
more, as described in the data subsection of the methods, the
physical protein interaction network was designed to be inde-
pendent of the discoveries stemming from GWAS and thus does
not contain any interactions discovered by text mining of the
literature after 2006 (initial period of GWAS publications).
GO-anchored information similarity between host genes of
intragenic SNPs
Disease networks were built from traitetrait similarities that
were calculated using the GO-anchored ITS between the traits’
genes. Trait genes were the host genes that harbor the variant
DNA sequence (SNPs) associated by GWAS with the trait. A
brief explanation of the procedure used to measure geneegene
similarity will follow and is directly calculated using our
published method (ﬁgures 2e4).
22
The similarity of two genes is deﬁned conceptually by the
similarity of their GO annotations as measured by their shared
information content. Speciﬁcally, the ITS of two terms is
deﬁned as the information content of their minimal ancestor in
GO (common ancestor with maximal information content)
divided by the average information content of the two
terms, where the information content of a single term is the
probability of the term and its sub-terms being selected
randomly in GO.
21 The formal deﬁnition of termeterm simi-
larity that we selected is Lin’s metric,
27 with straightforwardly
interpretable scores that range from ‘0’ (no similarity) to ‘1’
(100% similar)
22:
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where ic(a) is the information content of GO term a, ms(a,b) is
the minimal ancestor of terms a and b, G(a) is the sub-graph of
GO rooted at a, A is the root term of the GO, and the function
‘|G(a)|’ is the cardinality of G(a) measured as the count of
d i s t i n c tt e r m si nt h i ss u b - g r a p h .
The information content of a term is a non-negative value
representing the speciﬁcity of the term. For terms hierarchically
organized as an acyclic directed graph, the root term has zero
information content, as no speciﬁc information is generated
from this term because of its generality, while a leaf term with
great depth (distance from the root) has the largest information
content, since it is inherently more speciﬁc. Thus a term’s
information content is roughly related to its speciﬁcity.
Termeterm similarity is a value between 0 (for two terms
Table 1 Deﬁnitions and abbreviations
Concept Deﬁnition
Genome-wide association studies
(GWAS)
Investigation of genes in the whole genome for a large number of individuals that tests the genetic variations differentially found
between two contrasted groups (case vs control) with respect to a speciﬁc trait, such as a disease
Gene Ontology (GO) Controlled vocabulary of annotations to gene and gene product attributes
Proteineprotein interaction network
(PPIN)
Graphic representation of proteineprotein interactions on a large scale constructed in order to appreciate the network structure
Single-nucleotide polymorphism (SNP) Single-nucleotide variation in the genomic sequence found to be different between individuals or between two chromosomes
of the same individual
Intragenic SNP A SNP located within a gene region
Intergenic SNP A SNP located outside any gene region
Host gene of an intragenic SNP The gene that physically contains the intragenic SNP in its genomic sequence
Trait A characteristic phenotype or disease state of an individual, such as hair color or type II diabetes
Metatrait A class of disorders clinically related in time or sharing common molecular mechanisms (eg, ‘metabolic syndrome’ is a metatrait
for the traits ‘essential hypertension,’ ‘adult-onset diabetes mellitus’ and others)
Intertrait Relationship found between two traits
Intra-metatrait Connections between traits that belong to the same metatrait
Network modules A subnetwork possessing some biological or medical implications whose nodes are densely connected inside the subnetwork
but are sparsely connected with nodes outside of the subnetwork
Gene Ontology term Standardized description of a biological concept, such as the molecular function, the biological processes or the subcellular
localizations of a gene
Minimal ancestor of two GO terms The most speciﬁc GO term that could summarize or contain the characteristics shared between a pair of GO terms
NHGRI GWAS Catalog The National Human Genome Research Institute Catalog of Published Genome-Wide Association Studies (http://genome.gov/admin)
STRING Search tool for the retrieval of interacting genes/proteins: the most comprehensive database of proteineprotein interactions
and associations
Fusion A reliable proteineprotein interaction prediction method based on the hypothesis that two proteins are more likely to interact with
each other if they have been incorporated into a third protein as two domains during evolution
Shortest distance of two proteins The minimum number of distinct edges found among all possible routes connecting two proteins in a proteineprotein
interaction network
Shortest path(s) of two proteins All routes possessing the minimum number of distinct edges found among all possible routes connecting two proteins ina
proteineprotein interaction network
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two terms sharing identical sub-graphs and identical sets of
ancestors). More discussion on this GO-based similarity can be
found in our previous publication
22 and related review paper.
28
The ITS of two genes (Gene_ITS), such as two SNP host
genes, was measured by the average best-matching pair simi-
larity between their annotated GO terms. For any GO term
annotated to a gene, its best-matching term pair in another
gene’s GO annotation list is the one with the maximum
termeterm similarity as compared with all other terms from the
other gene. Furthermore, only the most reliable subset of the
best-matching term pairs across the two term sets is retained in
the calculation, while all other term pairs are ignored because of
the annotation noise in GO. Mathematically, the information
similarity of two genes is deﬁned as
22:
Gene ITSða;bÞ¼
23+ðai;biÞ˛p;ITSðai;biÞ$t ITSðai;biÞ
jajþjbj
(3)
where a and b are two genes being annotated to two term sets,
the included best-matching term pairs are represented as a rela-
tionship p with pairs ai and bi, and t is the similarity threshold
for any term pair to be included in the calculation for further
annotation noise reduction (set as 0.7 in our implementation
22).
The similarity of two genes is based on their number of shared
GO terms and, if the terms were not identical, the term prox-
imity in the GO graph. The information similarity of two genes
is normalized to the range of 0 to 1, corresponding to genes with
no similar annotations and genes with equivalent annotations,
respectively. More details and examples can be found in our
previous paper.
22
Traitetrait information similarity and empirical distributions
Traitetrait ITS (Trait_ITS or intertrait similarity) was measured
by the shared information between the host genes of the asso-
ciated intragenic SNPs, speciﬁcally the average similarity of
reciprocal best-matching host gene pairs from GWAS. The best-
matching pair of a host gene (g) with respect to another trait is
the host gene (d) of the other trait with maximum geneegene
similarity with the ﬁrst host gene (g). We required reciprocal
maximal similarity between host genes from two traits for the
most reliable relationship between traits, but did not use
a threshold to control noise because host genes derived from
intragenic SNPs are much more reliable than GO annotations
and contain much less noise. We deﬁne traitetrait similarity
formally as follows:
Trait ITSðU;VÞ¼
23+ðai;biÞ˛p’ Gene ITSðai;biÞ
jUj þ jVj
(4)
where U and Vare two traits representing two sets of host genes
identiﬁed by GWAS, and the reciprocal best-matching host gene
pairs are represented as a relationship p’ with pairs ai and bi. The
information similarity of two traits ranges from 0 (for two traits
with totally dissimilar host genes) to 1 (for two traits with
identical or equivalently annotated host genes).
In order to prioritize Trait_ITS scores, we conducted a permu-
tation resampling. We regarded the network directly derived from
GWAS as a bipartite network, with one set of nodes being the
diseases/traits (177) and the other set as the host genes (1083),
and shufﬂed the edges in the network so that the number of
degrees for any host gene or traits (nodes) remained the same. We
created 10000 such networks by permutation, and calculated an
empirical p value for each speciﬁc traitetrait connection
according to the rank of its observed Trait_ITS score among those
of that speciﬁc relationship in the control networks.
Disease similarity networks
A diseaseedisease network was thus constructed from pairwise,
intertrait similarities directly subjected to a certain joint simi-
larity and statistical signiﬁcance cut-off, where nodes in the
network represent complex traits, and edges represent the
signiﬁcant biological similarity between two traits as calculated
by ITS. The sizes of the nodes and edges were proportional to
the number of host genes and the strength of the traitetrait
similarities, respectively (ﬁgure 3).
Evaluation of metatrait biomodules
Clinically relevant modules in the diseaseedisease networks
were identiﬁed on the basis of expert knowledge as well as their
statistical signiﬁcance (ﬁgure 4). Traits were categorized into
metatraits by two clinicians blinded to the results (online
supplementary table 1). An ITS metatrait module is deﬁned as
a group of traits known to be subsumed by a metatrait that are
also predicted to be similar to one another by their Trait_ITS. We
further conducted an enrichment study to identify if these ITS
metatrait modules comprised more Trait_ITS connections than
expected using Fisher’s exact test, by considering two factors for
all possible trait pairs: (1) whether the trait pair was completely
within the metatrait of interest (intra-metatrait connection) or
if at least one of the traits was found outside of the metatrait
(non-intra-metatrait connection) and (2) whether the trait pair
Figure 2 Higher Gene Ontology (GO) similarity between proteins is
associated with smaller shortest distance in protein interaction
networks. Relationships are seen between average Gene_ITS values and
the shortest distance between pairs of proteins in the proteineprotein
interaction network. An average information theory similarity value was
calculated for groups of proteineprotein pairs in STRING v8.0 with the
same shortest distances (length value of shortest paths). As
hypothesized, higher biological similarity in GO was associated with
shorter distances in the protein interaction network (p<10
 16,
Spearman correlation, using the entire set of protein combinations
with GO annotations and protein interactions, which were 5753 and
5955 for GO biological processes (GO:BP) and GO molecular functions
(GO:MF), respectively). These results are reproducible in the subset
of genes hosting the single-nucleotide polymorphisms associated
with disease traits in the National Human Genome Research
Institute Catalog of Published Genome-Wide Association Studies
(data not shown).
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Research and applicationsFigure 3 Network of biological similarity between complex-disease traits calculated from genome-wide association study single-nucleotide
polymorphisms (SNPs). The disease similarity network was calculated using Genome Ontology biological process similarity of the host genes of trait-
associated intragenic SNPs with similarities $0.2 and an empirical p value <0.05. As shown, among 280 intertrait similarity connections (blue lines),
186 (66.4%) cannot be explained simply by shared host genes between the traits (gray lines) and are reported here for the ﬁrst time. Therefore, this
ﬁgure illustrates that our information theoretic similarity (ITS) method has found non-trivial relationships that would not have been found by
conventional methods. As hypothesized, metabolic syndrome traits (green) and cancer traits (purple) are signiﬁcantly enriched in connections with
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were made using a contingency table (table 2):
CMM ¼
jMj*ðjMj 1Þ
2
CTT ¼
jTj*ðjTj 1Þ
2
(5)
where M is a metatrait containing a set of related traits, T is the
set of all traits in the disease network. CMM is all possible
pairwise combinations of traits in M, and CTT is the total
possible pairwise combinations between all traits in the
network.
Metatraits enriched in Trait_ITS connections are deﬁned as
enriched ITS metatrait modules (deﬁned in table 2). Signiﬁcant
connections among ITS metatrait modules were examined in
closer detail by adding the shortest protein interaction path
between every pair of similar host genes associated with each
pair of diseases. See the Results section for a detailed rationale on
using the shortest protein interaction distance.
Overlaying a drug network
SNPs were associated with known drugs based on the Ingenuity
Knowledge Base. Each SNP dataset of interest was uploaded into
the application. Each identiﬁer was mapped to its corresponding
object in the Ingenuity Knowledge Base. SNPs with appropri-
ately mapped genes were deemed to be ‘network eligible mole-
cules’, and were overlaid on to a global molecular network
developed from information contained in the Ingenuity
Knowledge Base. Canonical drug information was then overlaid
on to the SNP network (online supplementary ﬁgure 3).
RESULTS
Biological signiﬁcance of geneegene similarity
Our initial study was designed to investigate the biological
validity of the geneegene ITS calculated from biological func-
tions and processes annotated to genes. We hypothesized that
biological similarity would increase with small shortest distance
in protein interaction networks. A high-quality subset of the
STRING database v8.0 (physical interactions) was used to
generate a genome-wide proteineprotein interaction network
(PPIN), which includes 72370 interactions for 7677 proteins
23
(ﬁgure 2, table 3). In addition, we investigated this correlation
between geneegene ITS and proteineprotein interactions in
the subset of genes hosting SNPs associated with disease traits
in the NHGRI GWAS Catalog
16 which includes 1083 disease
host genes and 1438 intragenic SNPs (online supplementary
table 2).
Table 3 shows the OR of biologically similar pairs of genes
enriched in ﬁrst-degree protein interactions on a genome scale,
and online supplementary table 2 corroborates these results on
the subset of genes associated with complex diseases through
GWAS. Speciﬁcally, direct proteineprotein interactions were
found to be enriched in geneegene pairs with similarities $0.7
(the empirical p values for the similarity $0.7 were 0.007 and
0.019 for GO:BP and GO:MF, respectively). For stratiﬁed
Gene_ITS thresholds, we calculated their enrichment in ﬁrst-
degree interactions (OR $14.6, p<10
 14 for Gene_ITS $0.7;
Fisher’s exact test) corresponding to (1) GO:BPs or (2) GO:MFs
either (3) over a genome-wide scale (table 3) or (4) on the subset
of genes associated with traits from the NHGRI GWAS Catalog
(online supplementary table 2).
We then investigated the interacting protein pairs with small
shortest distances and hypothesized that they are most likely to
have corresponding gene pairs with large similarity values.
Shortest protein interaction distances at either 1 or 2 (direct and
indirect neighbors, respectively) were found to be enriched in
gene pairs with a Gene_ITS $0.7 on a genome-wide scale (and at
the NHGRI SNP level), and for GO:BP and GO:MF alike (OR
>4.2 in the stringent PPIN; p<10
 6, Fisher’s exact test). These
results are consistent with other reports that indirect neighbors
may possess similar functions in PPINs.
25
Additionally, the shortest protein interaction distance
between two genes was found to inversely correlate with the
ITS value (ﬁgure 2). In other words, smaller shortest protein
interaction distances correlate with larger ITS scores between
genes. The non-parametric Spearman correlations between
information similarity and shortest distance in the stringent
PPIN were  0.15 and  0.09 for similarity of GO:BPs and GO:
MFs, respectively (p<2.2310
 16, using the entire set of protein
combinations). Other versions of STRING led to similar results
(data not shown), establishing the rationale for investigating
shortest paths using gene similarity associated with complex
traits in GWAS as seen in ﬁgure 4.
Diseaseedisease networks
Disease similarity networks were constructed from intertrait
similarity at a certain threshold, as deﬁned in Equation 4, which
makes use of host geneegene similarities as deﬁned in Equation
3 (Methods). Two disease similarity networks were constructed
using the information similarity of GO:BP and GO:MF terms
separately, as shown in ﬁgure 3 and online supplementary table
3 at an ITS of two traits $0.2 and a p value <0.05 and in online
supplementary ﬁgure 1 at an ITS of two traits $0.3 and
a p value <0.05 (Trait_ITS thresholds chosen by the minimal
value that guaranteed the statistical signiﬁcance of most values
above this cut-off). Additionally, the information connections
created by GO:BP similarity show stronger associations with
disease traits than those of GO:MFs. Thus, our subsequent
analysis focused on the networks created using GO:BPs. Two
hundred and eighty Trait_ITS relationships were selected as
signiﬁcant between traits (Trait_ITS $0.2; 138 of the 177 traits
in the selected network, ﬁgure 3). The connectivity of traits
with a large number of host genes is high, as expected. For
example, ‘diabetes mellitus type 1’ is associated with 40 host
genes in the NHGRI GWAS Catalog and is ranked ﬁfth among
177 traits in terms of number of host genes before Trait_ITS
analysis. Furthermore, after Trait_ITS analysis, the host genes of
‘diabetes mellitus type 1’ contributed signiﬁcantly to the
other traits in the same metatrait (p¼3.5310
 7 and 0.001 respectively, Fisher’s exact test). A signiﬁcant module of cancer traits (circled in orange) is
shown in greater detail in ﬁgure 4. Circles represent diseases or traits whose sizes are proportional to their number of associated intragenic SNP host
genes. Green circles represent metabolic syndrome-related traits curated a priori (dark green for metabolic syndrome traits and light green for their risk
factors), purple circles represent cancer traits, and gray circles represent other traits. Blue lines represent biological process similarities that are $0.2
and have a p value <0.05. Gray lines represent shared SNP host genes between diseases if their Trait_ITS is $0.2 (in other words overlapping
connections between our information theoretic method and conventional gene overlapping method). Line thicknesses are proportional to Trait_ITS
similarity values or number of shared genes. Solid lines have been validated as clinically meaningful by clinicians, while dotted lines have not.
[Continued]
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Research and applicationssimilarity network, which results in the greatest number of host
genes in the network and is represented as the largest node in
ﬁgure 3.
Traits in several metatraits were more likely to interact with
other traits in the same metatrait in the disease network. For
example, cancers (OR¼4.0; Fisher’s exact test p¼0.001) and
metabolic syndrome (OR¼3.1; Fisher’s exact test p¼3.5310
 7)
are shown to be enriched in signiﬁcantly similar traits (ﬁgure 3;
purple and green colors, respectively). By deﬁnition, metabolic
syndrome includes the disorders hypertension, arteriosclerosis,
adult-onset diabetes mellitus, hyperlipidemia, and obesity.
Different metabolic syndrome component diseases are expected
to share common genetic architecture, such as GO:BPs, and
should thus be related to one another, as should distinct cancer
types. A large metabolic syndrome module is shown in ﬁgure 3
(in green) along with two isolated cancer modules (in purple).
The module located in the bottom left of ﬁgure 3 outlined in
orange was examined in more detail in ﬁgure 4 because of its
novelty and clinical relevance.
We also constructed a disease network with a conventional
shared gene method using intragenic SNP host genes shared
between diseases for comparison with our ITS method. The
shared gene method has been previously reported in the litera-
ture, but with a much smaller set of GWAS data. The full disease
network created using shared genes is shown in online
Figure 4 Biological similarity
between cancer traits annotated by
shortest protein interaction path
between host genes is enriched in
oncogenes. The subset of ﬁgure 3
circled in orange corresponds to
a biomodule of cancer traits. (A)
provides the detailed view of their
genome-wide association study-
associated single-nucleotide
polymorphisms (SNPs), their
corresponding host genes, and their
dense biological similarities (Gene_ITS
$0.2; Trait_ITS $0.2; green lines;
based on Gene Ontology biological
processes). (B) provides an additional
annotation of shortest protein
interaction paths (red dotted lines)
between host genes. Oncogenes (gold
color) are statistically enriched in the
shortest protein-interaction paths
among pairs of SNP host genes
associated with distinct traits that were
paired by similarity measures
(p¼0.0001, Fisher’s exact test). In
addition, ﬁve out of six host genes
associated with these cancer traits are
either oncogenes or directly interact
with oncogenes in the cancer-related
modules in the disease network. Taken
together, our metric produces multi-
scale connections, as it contains
protein interactions as well as
biological similarities that both underlie
the disease network connections and
utilize different knowledge bases, thus
validating one another.
rs3914132
rs10974944
rs6435862
BARD1
rs4474514
rs995030
rs210138
rs4657482
Otosclerosis Neuroblastoma
Neoplasm
of testis 
Testicular
germ cell 
tumor
myeloproliferative
disorder
BAK1
JAK2
UCK2
KITLG
RELN
A
FANCA
MAPK8
RELN
AKT1
BARD1
BCL2
BAK1
STAT5B
KITLG
UCK2
SHC1 PCNA
JAK2
BRCA1
ITGB1
TP53
B
Table 2 Fisher’s exact test contingency table for enrichment of
a speciﬁc type of intra-metatrait connections in disease networks
Intra-metatrait
connections
Non-intra-metatrait
connections Subtotal
Observed in the network NMM NTT NMM NTT
Not observed in the network CMM NMM CTT CMM NTT+NMM CTT NTT
Subtotal CMM CTT CMM CTT
M, a metatrait containing a set of related traits; T, the set of all traits in the disease
network; NMM, the number of observed connections between the two traits within the
metatrait M; NTT, the number of connections in the disease network; CMM, all possible
pairwise combinations of traits in M; CTT, the total possible pairwise combinations between
all traits in the network.
Table 3 Direct proteineprotein interactions are enriched in geneegene
pairs with high biological similarity
Biological similarity between pairs of genes
(genome-wide)
GO biological process GO molecular function
ITS ‡0.7 ITS <0.7 ITS ‡0.7 ITS <0.7
Direct protein interaction
between pairs of genes
7314 41710 5413 47112
No direct protein
interactions
53174 16442890 138125 17537385
OR 53.7 14.6
Fisher’s exact test p<10
 16 p<10
 16
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Research and applicationssupplementary ﬁgure 2. It contains 383 connections between
137 combined traits with 40 isolated traits. The ‘skeletal ﬁnding’
trait was associated with the greatest number of host genes
(105, supplementary ﬁgure 2). Again, metabolic syndrome traits
were found to be signiﬁcantly more likely to interact with other
metabolic syndrome traits in the whole network constructed
using shared genes of trait-associated SNPs (OR¼4.1, Fisher’s
exact test p¼5.2310
 15), but cancer traits were not found to be
signiﬁcantly more likely to interact with other cancer traits
(OR¼1.7, Fisher’s exact test p¼0.22). This ﬁnding is mainly
consistent with the disease similarity network we constructed,
but is contrary to previous ﬁndings that most diseases in the
same disease classes (eg, metabolic syndrome) are isolated and
the whole network is only sparsely connected
19da conclusion
that may have arisen from insufﬁcient data. Gene overlap has
been previously published by Barrenas et al,
19 and interestingly
our Trait_ITS method recapitulates these ﬁndings and indicates
additional relationships for metabolic syndrome, such as the
Trait_ITS relationship between ‘birth weight ﬁnding’ and ‘risk
factor of diabetes and of obesity’. We later focused on the cancer
module in ﬁgure 4 and provided details of the ITS-generated
cancer biomodules showing underlying biological mechanisms
that explain the high Trait_ITS scores. As a proof-of-concept, we
also incorporated drug information into the aforementioned
cancer-speciﬁc biomodule (online supplemental ﬁgure 3).
To better compare the disease networks created by our
method and by the shared gene method, we plotted the shared
gene connections in the disease similarity network in a gray
color in ﬁgure 3. There were 114 traits in common between the
two networks out of 138 total traits in the disease similarity
network, indicating 82.6% trait coverage at a similarity
threshold of 0.2. In particular, there were 101 out of 114 (88.6%)
overlapping traits that shared at least one edge between these
networks, with 94 total overlapping connections that shared at
least one host gene and also possessed a GO:BP similarity $0.2.
One hundred and eighty-six non-trivial traitetrait connections
were identiﬁed by our ITS method because these pairs of traits
did not share SNPs, nor host genes of their respective SNPs. To
validate the accuracy of these newly discovered disease
connections, we conducted a preliminary manual validation on
the 280 similarity connections, and determined that 109 were
clinically reasonable, according to two clinician reviewers
(minimal precision of 38.9%). The genetic architecture of
complex traits may explain the apparently clinically irrelevant
relationships, as geneticists specializing in GWAS have observed,
particularly in Expression Quantitative Trait Loci (eQTL) studies
that show a subset of genes and SNPs that contribute to many
clinically unrelated diseases. In other words, the Trait_ITS
connections that do not corroborate obvious clinical relation-
ships may, in part, reﬂect the common modularity of complex-
disease gene inheritance as well. The comparative results
suggested that our similarity network contains many (186)
potential connections among complex traits that have not yet
been discovered by GWAS, and thus demonstrate that our ITS
method is able to capture non-trivial relationships that would
not have been otherwise found by conventional methods.
Finally, we conducted a smaller study focusing on Trait_ITS
scores derived exclusively from the 113 non-synonymous
(exonic) SNPs from the NHGRI GWAS Catalog. Trait_ITS scores
derived from this subset were signiﬁcantly higher than those
obtained from the whole collection and from intronic ones
(p<2310
 16 and p<2310
 16, ManneWhitney test; 113 non-
synonymous SNPs versus (1) 2793 intragenic SNPs and (2) 1137
intronic SNPs; p values of Trait_ITS scores led to similar results).
These results suggest that polymorphism is more likely to be
associated with missense or stop codon mutations, and conse-
quently mutated proteins are more likely to be functionally
similar by Trait_ITS than intronic sequences. However, the
number of intertraits evaluated thus far is relatively small, and
future studies may require a larger collection of exonic non-
synonymous SNPs.
Disease similarity biomodule: cancer module case study
We focused our attention on one of the more interesting cancer
modules, and plotted the shortest paths among the disease-
associated genes in the PPIN in which the similarity of biological
processes was positive (as shown in ﬁgure 4) because of the
correlation between geneegene similarity and shortest protein
interaction distance. This disease similarity biomodule contains
four distinct disorders that suggest a common genetic architec-
ture for a cancer ‘metatrait’ associated with germline mutations
or those arising early in life (shown in ﬁgure 4A). Two of the
diseases are cancers, speciﬁcally neuroblastoma and testicular
cancer (neoplasm of testis and testicular germ cell tumor).
Furthermore, another class of diseases in the network, myelo-
proliferative disorders, contains precancer and cancer, and
includes polycythemia vera and chronic myelogenous leukemia,
among others. The ﬁnal constituent is otosclerosis, a disease
causing hearing loss that has been found to be a Tcell-mediated
autoimmune disorder involving abnormal bone growth in the
middle ear.
29 Interestingly, both neuroblastoma and neoplasms
of the testis are found in younger patients and most commonly
involve germline mutations of speciﬁc genes that cause these
phenotypes. Similarly, both otosclerosis and myeloproliferative
disorders have speciﬁc childhood variations similarly arising
from heritable mutations, causing manifestations in early life.
Although seemingly disparate, these diseases share a strong
underlying genetic and clinical component. Indeed, among the
16 proteins connecting the diseases in the shortest path network
shown in ﬁgure 4B, six are oncogenes as curated by the Sanger
Institute.
30 This is statistically signiﬁcant and corresponds to an
OR of 10.8 (408 cancer genes in total) with a p value¼0.0001
(Fisher’s exact test). Moreover, except for the host gene, UCK2,
which is not annotated by GO, all other host genes associated
with the ﬁve diseases are either oncogenes or directly interact
with oncogenes.
Furthermore, we recapitulate known oncogenic pathways in
our model, such as KITLG and JAK2, between testicular cancer
and myeloproliferative disease. We also highlighted other shared
pathways. For example, the gene product of KITLG is a ligand of
a tyrosine kinase receptor involved explicitly in neuronal and
germ cell development as well as hematopoiesis, a process that
continues through adulthood. KITLG and its associated SNP
(rs995030) are directly connected to testicular cancer,
31 but have
also be shown to be involved in myeloproliferative disorders
32
via their role in hematopoiesis, and are conceivably connected to
neuroblastoma with its involvement in neuronal development
and migration. RELN similarly functions to regulate the
migration of neuroblasts and is directly connected to otosclerosis
in our network as well as in the literature.
33 Not surprisingly,
RELN’s importance in neuroblastoma has been previously
documented,
34 and, correspondingly, our disease similarity
network created a putative linkage through protein associations
with AKT1, FANCA, and BARD1, consecutively.
JAK2 is a tyrosine kinase associated with cytokine receptors
involved in cell signaling pathways mediating gene transcription
as well as other cellular functions. It is a necessary component of
hematopoiesis, and thus speciﬁc gain-of-function mutations in
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involved in all other myeloproliferative disorders.
35 Similarly,
other mutations in JAK2 can contribute to the formation of many
different neoplasms, plausibly conﬁrming the connections made
in our diagram through JAK2 to both testicular cancer and
neuroblastoma via several different pathways. Therefore, the
disease similarity biomodule reveals commonalities on both the
phenotypic and molecular levels such as their host genes’ simi-
larities and the intermediate genes connecting similar host genes.
DISCUSSION AND CONCLUSION
In this study, we explored a method for understanding diseasee
disease similarities at both the phenotypic and molecular levels
simultaneously. To do this, we took advantage of information
theory metrics of trait similarity that are deﬁned using host
geneegene similarities derived from GWAS intragenic SNP data.
Thus, the similarity arising between these traits from GO
annotations at the molecular level can be qualitatively validated
by observing if a signiﬁcant number of known related clinical
diseases are also related by their genetic similarity. Accordingly,
we demonstrated the potential of using intragenetic SNPs to
explain disease associations in a cancer biomodule. Furthermore,
to quantitatively validate GO functional similarity, we assumed
that, among a variety of biological mechanisms relating genes,
the shortest distance for each protein pair can be calculated
independently. We indeed conﬁrmed that the shortest distance
in the entire diseaseegene PPIN, calculated exclusively from
protein interactions and independently from GO similarity,
correlate with higher GO similarity between the genes of
disease-associated intragenic SNPs.
To visualize these results in the context of disease, we
generated a composite diseaseegene network comprising simi-
larity connections between traits and the shortest paths in the
PPIN between disease genes. We found clear biomodules that
have shared pathways and clinical traits and thus merit further
exploration. By generating novel genetic connections between
diseases, this technique can be used to focus the scope of
investigation, and, by being computational in nature, has the
potential to elucidate disease underpinnings with a reduced need
for conventional wet-lab methods.
Moreover, we have demonstrated the ability to layer pharma-
cologic data on to our network for potential future hypothesis
generation. In our analysis, the network-associated drugs may be
useful in chemoprevention, as patients with the affected SNP
were more likely to develop a disease. However, it is important to
note that the very nature of GWAS indicates that the SNPs used
in our study are associated with (and not causal of) disease
susceptibility. Thus, while it is possible to speculate on the
potential role of pharmacology in our network, it is critical that
the underlying mechanisms in the SNPegeneedisease triad ﬁrst
be better understood. In other words, when causation is estab-
lished, pharmacologic agents captured at the gene/protein level
have a far higher likelihood of being effective agents. Neverthe-
less, despite this limitation of the SNP data, our method provides
researchers with a crucial starting point for testing repurposed
drugs in their model systems of disease in conjunction with
previously validated methods. Previous informatics studies have
shown the opportunity to reposition drugs using structural and
functional similarity between proteins within the scope of ‘gene
targeting’
36 and through a new paradigm of genome-based drug
repositioning.
37e39
Another limitation of our study is that there are more inter-
genic SNPs (SNPs located outside of gene regions) than intra-
genic SNPs (found within genes) identiﬁed through the NHGRI
GWAS Catalog, and our approach cannot, by design, ﬁnd
meaning for these intergenic SNPs. The ways in which inter-
genic SNPs inﬂuence disease are of particular interest to biolo-
gists and physicians. Thus, we are currently developing other
measures for the similarity of those SNPs, using mechanisms
such as microRNAs and other regulatory elements, which we
believe strongly associate diseases with one another, since
proteineprotein interactions are not the only mechanism by
which diseases are connected. Further, the biological similarity of
two traits anchored on Information Theory is assigned
according to the GO terms annotated to the genes hosting the
GWAS-associated SNPs, and thus each pair of traits may have
a different number of host genes and a different number of GO
annotations to these genes. We completed comprehensive
empirical distributions for each pair of traits to obtain a p value
speciﬁc to the similarity score of each pair of traits. In future
studies, intertrait similarity connections will be constructed by
combining these empirical probabilities with much lower simi-
larity scores to calculate thresholds rather than using a stringent
threshold based mainly on the similarity score as we did in this
study. We expect to cover more intertrait connections with
shared genes at lower but signiﬁcant ITS scores. Finally, there
may be multiple shortest PPIN paths between similar host
genes. In these cases, we selected one path, and we will explore
alternates in the future.
In this study, we explored trait-associated intragenic SNPs
discovered in GWAS and developed a novel measure for intertrait
similarity based on the host genes of these SNPs. We found
correlations between SNP-associated geneegene ITS values and
the shortest proteineprotein interaction paths, which were then
used to discover potential associations among diseases. The case
study demonstrates the utility of such an approach and suggests
a novel genetic architecture of complex diseases, beyond
straightforward SNP or gene overlap, and canonical pathway
analyses. Although identifying the mechanisms and genetic
pathways that cause these diseases from GWAS SNPs has been
vexing, our network provides a means of hypothesis generation
by establishing mechanistic/functional groupings of traits by
originating our study from these SNPs. Additionally, we
achieved modularity of the mechanism/function-anchored
similarity network by grouping these traits into possible meta-
traits that recapitulate, in part, known relationships such as
‘cancers’ and ‘metabolic syndrome’ and identify potential new
connections. Thus, by delving into shared phenotypic and
genetic similarity of biomodules, SNP-associated networks hold
promise for understanding the genetic architecture of complex
pathophysiological conditions. Further, the proposed network
differs fundamentally from canonical ones that are manually
curated by biologists, which by deﬁnition are limited to existing
biologically validated knowledge. In contrast, unbiased ‘biolog-
ical similarity’ and ‘protein interaction’ networks anchored on
genetic polymorphisms allow exploration of non-canonical
mechanisms underpinning diseases. One can use drugs devel-
oped for one disease for another with shared molecular mecha-
nisms, which differs from current drug development paradigms
reliant on single-gene targets and known canonical pathways.
This approach also provides testable hypotheses for drug repo-
sitioning anchored on three scales of biology: biological function
similarity, protein interactions, and genetic polymorphisms. We
propose that unbiased ‘network targeting’ methods have the
potential to invigorate the investigation of therapeutic targets.
In summary, we report a biological similarity network that
demonstrates the genetic architecture of complex diseases
derived from intragenic SNPs.
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